Authors:
Ekins, S
Durst, GL
Stratford, RE
Thorner, DA
Lewis, R
Loncharich, RJ
Wikel, JH
Citation: S. Ekins et al., Three-dimensional quantitative structure-permeability relationship analysis for a series of inhibitors of rhinovirus replication, J CHEM INF, 41(6), 2001, pp. 1578-1586
Citation: G. Bravi et Jh. Wikel, Application of MS-WHIM descriptors: 1. Introduction of new molecular surface properties and 2. Prediction of binding affinity data, QSAR, 19(1), 2000, pp. 29-38
Authors:
Ekins, S
Bravi, G
Binkley, S
Gillespie, JS
Ring, BJ
Wikel, JH
Wrighton, SA
Citation: S. Ekins et al., Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors, DRUG META D, 28(8), 2000, pp. 994-1002
Authors:
Ekins, S
Ring, BJ
Bravi, G
Wikel, JH
Wrighton, SA
Citation: S. Ekins et al., Predicting drug-drug interactions in silico using pharmacophores: A paradigm for the next millennium, IUL BIOTECH, 2, 2000, pp. 269-299
Authors:
Bastian, JA
Chirgadze, N
Denney, ML
Gifford-Moore, DS
Sall, DJ
Smith, GF
Wikel, JH
Citation: Ja. Bastian et al., Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain, BIOORG MED, 9(3), 1999, pp. 363-368
Authors:
Ekins, S
Bravi, G
Binkley, S
Gillespie, JS
Ring, BJ
Wikel, JH
Wrighton, SA
Citation: S. Ekins et al., Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors, PHARMACOGEN, 9(4), 1999, pp. 477-489
Authors:
Ekins, S
Bravi, G
Binkley, S
Gillespie, JS
Ring, BJ
Wikel, JH
Wrighton, SA
Citation: S. Ekins et al., Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors, J PHARM EXP, 290(1), 1999, pp. 429-438
Authors:
Takeuchi, K
Kohn, TJ
True, TA
Mais, DE
Wikel, JH
Utterback, BG
Wyss, VL
Jakubowski, JA
Citation: K. Takeuchi et al., Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds, J MED CHEM, 41(27), 1998, pp. 5362-5374